splenopentin has been researched along with Benign Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, SS; Biswas, S; Garg, SK; Haq, W; Mathur, KB; Singh, VK | 1 |
1 review(s) available for splenopentin and Benign Neoplasms
| Article | Year |
|---|---|
Thymopentin and splenopentin as immunomodulators. Current status.
Topics: Adjuvants, Immunologic; Animals; Autoimmune Diseases; Child; Dermatitis; Humans; Immunologic Deficiency Syndromes; Infections; Myasthenia Gravis; Neoplasms; Neuromuscular Agents; Peptide Fragments; Thymopentin; Thymopoietins | 1998 |